Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.45
(0.0%)
CNY 7.45
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 62.87 Million CNY | -48.3% |
| 2022 | 121.6 Million CNY | 125.8% |
| 2021 | 53.85 Million CNY | 267.5% |
| 2020 | -32.15 Million CNY | -21.75% |
| 2019 | -26.4 Million CNY | -224.0% |
| 2018 | 21.29 Million CNY | -81.27% |
| 2017 | 113.73 Million CNY | 32.97% |
| 2016 | 85.53 Million CNY | -10.34% |
| 2015 | 95.4 Million CNY | -5.75% |
| 2014 | 101.22 Million CNY | -14.79% |
| 2013 | 118.78 Million CNY | 5.55% |
| 2012 | 112.54 Million CNY | 4.91% |
| 2011 | 107.27 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.71 Million CNY | 68.56% |
| 2024 Q3 | 5.04 Million CNY | -73.21% |
| 2024 Q2 | 18.84 Million CNY | 606.65% |
| 2023 Q1 | 14.23 Million CNY | -82.54% |
| 2023 FY | 62.87 Million CNY | -48.3% |
| 2023 Q2 | 30.44 Million CNY | 113.85% |
| 2023 Q4 | -11.82 Million CNY | -68.02% |
| 2023 Q3 | -7.03 Million CNY | -123.12% |
| 2022 Q3 | 14.03 Million CNY | -20.62% |
| 2022 FY | 121.6 Million CNY | 125.8% |
| 2022 Q4 | 81.54 Million CNY | 481.13% |
| 2022 Q1 | 10.59 Million CNY | -38.77% |
| 2022 Q2 | 17.67 Million CNY | 66.84% |
| 2021 FY | 53.85 Million CNY | 267.5% |
| 2021 Q1 | 13.33 Million CNY | 523.96% |
| 2021 Q2 | 10.45 Million CNY | -21.64% |
| 2021 Q3 | 7.93 Million CNY | -24.1% |
| 2021 Q4 | 17.3 Million CNY | 118.14% |
| 2020 Q4 | 2.13 Million CNY | -57.73% |
| 2020 Q1 | 6.06 Million CNY | 153.93% |
| 2020 Q3 | 5.05 Million CNY | 216.6% |
| 2020 Q2 | -4.33 Million CNY | -171.45% |
| 2020 FY | -32.15 Million CNY | -21.75% |
| 2019 Q1 | 6.48 Million CNY | 125.76% |
| 2019 FY | -26.4 Million CNY | -224.0% |
| 2019 Q2 | 9.13 Million CNY | 40.75% |
| 2019 Q4 | -11.25 Million CNY | -244.62% |
| 2019 Q3 | 7.78 Million CNY | -14.8% |
| 2018 Q1 | 20.61 Million CNY | -31.03% |
| 2018 FY | 21.29 Million CNY | -81.27% |
| 2018 Q4 | -25.19 Million CNY | -274.46% |
| 2018 Q3 | 14.44 Million CNY | 26.26% |
| 2018 Q2 | 11.43 Million CNY | -44.52% |
| 2017 Q1 | 24.93 Million CNY | 75.17% |
| 2017 FY | 113.73 Million CNY | 32.97% |
| 2017 Q4 | 29.88 Million CNY | -0.42% |
| 2017 Q3 | 30.01 Million CNY | 3.88% |
| 2017 Q2 | 28.89 Million CNY | 15.86% |
| 2016 Q2 | 22.86 Million CNY | -18.88% |
| 2016 FY | 85.53 Million CNY | -10.34% |
| 2016 Q3 | 20.24 Million CNY | -11.45% |
| 2016 Q1 | 28.18 Million CNY | 30.8% |
| 2016 Q4 | 14.23 Million CNY | -29.68% |
| 2015 Q1 | 29 Million CNY | 56.54% |
| 2015 FY | 95.4 Million CNY | -5.75% |
| 2015 Q4 | 21.54 Million CNY | 1.95% |
| 2015 Q3 | 21.13 Million CNY | -10.84% |
| 2015 Q2 | 23.7 Million CNY | -18.28% |
| 2014 FY | 101.22 Million CNY | -14.79% |
| 2014 Q3 | 29.81 Million CNY | 40.38% |
| 2014 Q1 | 31.64 Million CNY | 0.0% |
| 2014 Q2 | 21.23 Million CNY | -32.89% |
| 2014 Q4 | 18.53 Million CNY | -37.84% |
| 2013 FY | 118.78 Million CNY | 5.55% |
| 2012 FY | 112.54 Million CNY | 4.91% |
| 2011 FY | 107.27 Million CNY | 0.0% |